EMDR and Imagery Rescripting as a Treatment for Trauma-Related Intrusive Images

EMDR and Imagery Rescripting as a Treatment for Trauma-Related Intrusive Images - EMDR and Imagery Rescripting for Trauma-Related Intrusions

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON56857

Enrollment

Registered

2023-12-05

Start date

2025-01-27

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression PTSD depression PTSD

Interventions

Patients will be randomly assigned to EMDR or IR. In each condition, patients will receive two 75-minute sessions of EMDR or IR each week, as well as an additional coaching session each week. Treatm

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age between 18 and 70 years; - Experiencing intrusions and/or nightmares; - Meet criteria for unipolar depressive disorder, PTSD, or both disorders; - Past aversive events still cause considerable distress; - Be available for trauma treatment twice a week, with an additional coaching session each week; - Be proficient in the Dutch language.

Exclusion criteria

Exclusion criteria: - A dissociative identity disorder; - Acute suicide risk; - Acute psychosis; - Substance use disorder; - Bipolar disorder type 1 and 2.

Design outcomes

Primary

Measure	Time frame
The primary outcome is a brief measure of characteristics of intrusions (specifically, the frequency, uncontrollability, and degree of interference with daily life), which will be assessed twice daily via an online link. Additionally, process measures indexing possible mediators concern brief questionnaires on emotion regulation, self-compassion, rumination, positive affect, and the vividness, distress, and related meaning of intrusions, which also serve as our primary outcome measures. These questionnaires will be assessed daily. All primary outcome measures will be administered during the baseline, experimental, and withdrawal phase.	—

Measure

Time frame

The primary outcome is a brief measure of characteristics of intrusions (specifically, the frequency, uncontrollability, and degree of interference with daily life), which will be assessed twice daily via an online link. Additionally, process measures indexing possible mediators concern brief questionnaires on emotion regulation, self-compassion, rumination, positive affect, and the vividness, distress, and related meaning of intrusions, which also serve as our primary outcome measures. These questionnaires will be assessed daily. All primary outcome measures will be administered during the baseline, experimental, and withdrawal phase.

—

Secondary

Measure	Time frame
Secondary outcome measures concern questionnaires on quality of life, depression symptoms, and PTSD symptoms which are endorsed at baseline, post-treatment (i.e., 4 weeks after the last intervention session, at the end of the withdrawal phase), and at 6-month follow-up. A questionnaire about outcome expectancies will be administered at baseline, and weekly during the treatment phase.	—

Countries

Netherlands

Contacts

Public ContactC. J. P. Simons

GGzE

claudia.simons@ggze.nlGGzE: +31-40-2970170

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026